| Gene symbol | MME | Synonyms | CALLA, CD10, CMT2T, NEP, SCA43, SFE | Type of gene | protein-coding |
| Chromosome | 3 | Map location | 3q25.2 | dbXrefs | |
| Description | membrane metalloendopeptidase | ||||
| Gene symbol | IL3RA | Synonyms | CD123, IL-3R-alpha, IL3R, IL3RAY, IL3RX, IL3RY, hIL-3Ra | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | interleukin 3 receptor subunit alpha | ||||
| Gene symbol | MS4A1 | Synonyms | B1, Bp35, CD20, CVID5, FMC7, LEU-16, S7 | Type of gene | protein-coding |
| Chromosome | 11 | Map location | 11q12.2 | dbXrefs | |
| Description | membrane spanning 4-domains A1 | ||||
| Gene symbol | CD22 | Synonyms | SIGLEC-2, SIGLEC2 | Type of gene | protein-coding |
| Chromosome | 19 | Map location | 19q13.12 | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | PertOrg | ||||
| Description | CD22 molecule | ||||
| Gene symbol | CD38 | Synonyms | ADPRC 1, ADPRC1, cADPR1 | Type of gene | protein-coding |
| Chromosome | 4 | Map location | 4p15.32 | dbXrefs | |
| Gene perturbation-related omics dataset | PertOrg | ||||
| Description | CD38 molecule | ||||
| Gene symbol | CRLF2 | Synonyms | CRL2, CRLF2Y, TSLPR | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Gene perturbation-related omics dataset | PerturbAtlas | ||||
| Description | cytokine receptor like factor 2 | ||||
| GTO ID | GTC2145 |
| Trial ID | NCT04016129 |
| Disease | B-Cell Acute Lymphoblastic Leukemia |
| Altered gene | CD22|CD123|CD38|CD10|CD20|TSLPR |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | CAR-T cells |
| Generation | 4th |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | CAR-T Immunotherapy Targeting CD19- ALL |
| Year | 2019 |
| Country | China |
| Company sponsor | Shenzhen Geno-Immune Medical Institute |
| Other ID(s) | GIMI-IRB-19003 |
| Cohort 1 | |||||||
|
|||||||